Bell Rock Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-100
| Closed | -$1K | – | 337 |
|
|
2019
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 377 |
|
|
2019
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 359 |
|
|
2019
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 367 |
|
|
2019
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 408 |
|
|
2018
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 397 |
|
|
2018
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 407 |
|
|
2018
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 413 |
|
|
2018
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 409 |
|
|
2017
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 391 |
|
|
2017
Q3 | $3K | Hold |
100
| – | – | ﹤0.01% | 380 |
|
|
2017
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 391 |
|
|
2017
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 344 |
|
|
2016
Q4 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 341 |
|